[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100647830":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":36,"centralContacts":36,"locations":36,"responsibleParty":37,"collaborators":36,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":36,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":36,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":60,"whyStopped":36,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":36},{"fullName":5,"class":6},"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","OTHER",[8,14,18,21,24,27],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1: Implantation of the Clareon Vivity intraocular lens","EXPERIMENTAL","EDoF IOL",[13],"Device: Intraocular lens",{"label":15,"type":10,"description":16,"interventionNames":17},"Group 2: Implantation of the TECNIS Eyhance intraocular lens","Enhanced monofocal IOL",[13],{"label":19,"type":10,"description":16,"interventionNames":20},"Group 3: Implantation of the RayOne EMV intraocular lens",[13],{"label":22,"type":10,"description":16,"interventionNames":23},"Group 4: Implantation of the IsoPure Serenity intraocular lens",[13],{"label":25,"type":10,"description":16,"interventionNames":26},"Group 5: Implantation of the Vivinex Impress intraocular lens",[13],{"label":28,"type":10,"description":11,"interventionNames":29},"Group 6: Implantation of the TECNIS PureSee intraocular lens",[13],[31],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"DEVICE","Intraocular lens","Implantation of intraocular lens",[9,15,19,22,25,28],null,{"type":38,"investigatorFullName":36,"investigatorTitle":36,"investigatorAffiliation":36,"oldNameTitle":36,"oldOrganization":36},"SPONSOR","100647830","clinical-trial-on-the-visual-function-of-enhanced-monofocal-and-edof-intraocular-lenses-100647830",false,"NCT07715071","Clinical Trial on the Visual Function of Enhanced Monofocal and EDoF Intraocular Lenses","Randomized Clinical Trial to Evaluate the Visual Function of Enhanced Monofocal and Extended Depth of Field Intraocular Lenses","INCLUSION CRITERIA:\n\n* Patients with bilateral cataracts at different stages of development.\n* Patients with functional visual demands.\n* Age between 45 and 80 years.\n* Male or female sex.\n* Ability to provide informed consent.\n\nEXCLUSION CRITERIA:\n\nPreoperative Exclusion Criteria\n\n• Medical criteria:\n\nCorneal astigmatism greater than 1.0 diopter. Pre-existing ocular pathology. Previous refractive surgery. Previous corneal or intraocular implant. Poor general health status or potentially reduced neuroadaptation capacity due to previous stroke, Alzheimer's disease, other forms of dementia, etc.\n\nUnrealistic postoperative visual expectations.\n\nIntraoperative Withdrawal Criteria\n\n* Vitreous loss.\n* Pupillary trauma.\n* Factors likely to affect the medium-term performance of the intraocular lens: Zonular damage, Capsulorhexis tear or injury, Capsular rupture, Endothelial damage.","ALL","45 Years","80 Years",{"count":50,"type":51},90,"ESTIMATED","INTERVENTIONAL",[54],"NA","Randomized clinical trial to evaluate the visual performance of enhanced monofocal and extended depth-of-field intraocular lenses",[57],"Cataract",[33,57,59,11],"Enhanced monfocoal IOL","NOT_YET_RECRUITING","2026-07-15",{"date":63,"type":64},"2026-07-20","ACTUAL",{"date":66,"type":51},"2026-09-21",{"date":68,"type":51},"2027-03-31",{"name":5,"class":6}]